Literature DB >> 3079728

In vitro cultivation of Toxoplasma gondii cysts in astrocytes in the presence of gamma interferon.

T C Jones, K A Bienz, P Erb.   

Abstract

Long-term culturing of Toxoplasma gondii cysts was accomplished in vitro in association with murine astrocytes and intermittent additions of gamma interferon to the media. Phase-contrast microscopy was used to follow the stages of cyst development, and electron microscopy confirmed the presence of morphologic characteristics of T. gondii cysts. T. gondii cysts formed in vitro had a single trilaminar membrane during both intracellular and extracellular existence and contained amorphous electron-dense material either throughout the cyst or in a uniform layer under the trilaminar membrane. The bradyzoites were similar to previous descriptions of tachyzoites in vitro except that they were smaller and contained numerous electron-lucent vacuoles. Gamma interferon is not necessary for cyst formation, but it controls the division of tachyzoites and may allow cysts to remain for prolonged periods without rupturing. In vitro-cultivated T. gondii cysts will be useful for producing bradyzoite and cyst antigens and for measuring the effects of antimicrobial agents and immune modulators on the viability of intracystic T. gondii.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3079728      PMCID: PMC261078          DOI: 10.1128/iai.51.1.147-156.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  The effect of sulfomethoxypyrazine-pyrimethamine therapy on the fine structure of Toxoplasma gondii-cysts in the brain of Mastomys natalensis. Scanning and transmission electron microscopical investigations.

Authors:  F R Matuschka
Journal:  Zentralbl Bakteriol Orig A       Date:  1977-07

2.  Toxoplasma gondii cysts in cell culture: new biologic evidence.

Authors:  R L Hoff; J P Dubey; A M Behbehani; J K Frenkel
Journal:  J Parasitol       Date:  1977-12       Impact factor: 1.276

3.  Structural changes of Toxoplasma gondii bradyzoites and cysts following therapy with sulfamethoxypyrazine-pyrimethamine: studies by light and electron microscopy. Consequences for chemotherapy.

Authors:  H Werner; F R Matuschka; I Brandenburg
Journal:  Zentralbl Bakteriol Orig A       Date:  1979-10

4.  Immunohistological study of the anatomic relationship of toxoplasma antigens to the inflammatory response in the brains of mice chronically infected with Toxoplasma gondii.

Authors:  F K Conley; K A Jenkins
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

5.  Modification of subclinical toxoplasmosis in mice by cortisone, 6-mercaptopurine and splenectomy.

Authors:  W Stahl; H Matsubayashi; S Akao
Journal:  Am J Trop Med Hyg       Date:  1966-11       Impact factor: 2.345

6.  Immunosuppression and toxoplasmic encephalitis: clinical and experimental aspects.

Authors:  J K Frenkel; B M Nelson; J Arias-Stella
Journal:  Hum Pathol       Date:  1975-01       Impact factor: 3.466

7.  In vitro induction of nonspecific resistance in macrophages by specifically sensitized lymphocytes.

Authors:  J L Krahenbuhl; J S Remington
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

8.  Primary and reactivated toxoplasma infection in patients with cardiac transplants. Clinical spectrum and problems in diagnosis in a defined population.

Authors:  B J Luft; Y Naot; F G Araujo; E B Stinson; J S Remington
Journal:  Ann Intern Med       Date:  1983-07       Impact factor: 25.391

9.  Assessment in vitro of immunity against Toxoplasma gondii.

Authors:  T C Jones; L Len; J G Hirsch
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

10.  The interaction between Toxoplasma gondii and mammalian cells. II. The absence of lysosomal fusion with phagocytic vacuoles containing living parasites.

Authors:  T C Jones; J G Hirsch
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

View more
  37 in total

Review 1.  The development and biology of bradyzoites of Toxoplasma gondii.

Authors:  L M Weiss; K Kim
Journal:  Front Biosci       Date:  2000-04-01

2.  Presence of gamma interferon in human acute and congenital toxoplasmosis.

Authors:  J Raymond; M H Poissonnier; P H Thulliez; F Forestier; F Daffos; P Lebon
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 3.  Effects of Toxoplasma gondii infection on the brain.

Authors:  Vern B Carruthers; Yasuhiro Suzuki
Journal:  Schizophr Bull       Date:  2007-02-23       Impact factor: 9.306

4.  Characterization of bradyzoite-specific antigens of Toxoplasma gondii.

Authors:  S Tomavo; B Fortier; M Soete; C Ansel; D Camus; J F Dubremetz
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

5.  Investigation of tissue cysts in the retina in a mouse model of ocular toxoplasmosis: distribution and interaction with glial cells.

Authors:  Hyun Beom Song; Bong-Kwang Jung; Jin Hyoung Kim; Young-Ha Lee; Min-Ho Choi; Jeong Hun Kim
Journal:  Parasitol Res       Date:  2018-06-02       Impact factor: 2.289

6.  Bradyzoite development in Toxoplasma gondii and the hsp70 stress response.

Authors:  L M Weiss; Y F Ma; P M Takvorian; H B Tanowitz; M Wittner
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

Review 7.  Toxoplasma gondii and ocular toxoplasmosis: pathogenesis.

Authors:  C E Pavesio; S Lightman
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

Review 8.  Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts.

Authors:  J P Dubey; D S Lindsay; C A Speer
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

9.  A morphological study of chronic cerebral toxoplasmosis in mice: comparison of four different strains of Toxoplasma gondii.

Authors:  D J Ferguson; J Huskinson-Mark; F G Araujo; J S Remington
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

10.  Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion.

Authors:  W Bohne; J Heesemann; U Gross
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.